[ORGANIZATION]
Twist Bioscience
Featured in 8 tracked stories · first seen
Situations
Anthropic Claude AI scientific research applications
2 clusters · 9 sources · last updated
Latest: Anthropic’s Claude AI designs protein binders for scorpion neurotoxins
Anthropic’s Claude AI model has demonstrated capabilities in biological discovery and protein design. In one instance, the AI identified a new family of biological molecules called array-associated reverse transcriptases
Anthropic Claude AI development and application
19 clusters · 346 sources · last updated
Latest: Anthropic to restrict abusive behavior toward Claude AI
In September 2026, Anthropic released Claude Fable 5.1 and Claude Mythos 5.1. These models feature improved technical benchmarks and more precise safety guardrails, reducing false positives in cybersecurity and biology.
AI agents: autonomy, security, and standardized workflows
35 clusters · 96 sources · last updated
Latest: AI agent advancements focus on automated data analysis and cost tracking
AI productivity agents are evolving toward structured production tools, though technical, architectural, and economic hurdles persist. While development shifts toward a five-level autonomy scale, security and infrastruct
US stock market volatility and rising Treasury yields
17 clusters · 203 sources · last updated
Latest: S&P 500 index shows mixed signals amid high valuations and technical resistance
By late October 2026, the S&P 500 has continued to navigate volatility characterized by high valuations and market concentration. While the index has maintained a year-to-date increase of approximately 12% to 13.8%, anal
Twist Bioscience and Eli Lilly AI partnership
2 clusters · 3 sources · last updated
Latest: Twist Bioscience shares surge on Eli Lilly AI partnership
Twist Bioscience experienced a significant increase in stock value following the announcement of a partnership with Eli Lilly. The collaboration involves Twist Bioscience providing antibody characterization data services